Evidence map›Paper›PMID 31119084›Full record

ArticlePeerJ2019

Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway.

Ruoxi Yu, Zhi Li, Chuang Zhang, Huicong Song, Mingming Deng, Liping Sun, Ling Xu, Xiaofang Che, Xuejun Hu, Xiujuan Qu and 2 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ruoxi Yu *Department of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Zhi Li *Department of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Chuang ZhangDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Huicong SongDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Mingming DengKey Laboratory of Anticancer Drugs and Biotherapy, Shenyang, China.
Liping SunTumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, Shenyang, China.
Ling XuDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Xiaofang CheDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Xuejun HuDepartment of Respiratory and Infectious Disease of Geriatrics, the First Affiliated Hospital of China Medical University, Shenyang, China.
Xiujuan QuDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Yunpeng LiuDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
Ye ZhangDepartment of Medical Oncology, the First Affiliated Hospital of China Medical University, Shenyang, China.
China Medical University · CNShenyang Pharmaceutical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limb-bud and heart development (LBH) gene is a highly conserved, tissue-specific transcription cofactor in vertebrates that regulates multiple key genes in embryonic development. The role of LBH in various cancer types is still controversial, and its specific role and molecular mechanism in the oncogenesis of gastric cancer (GC) remains largely unexplored. In the present study, the prognostic significance and clinicopathological characteristics of LBH in GC was determined. The LBH mRNA expression was first investigated in four independent public datasets (TCGA-STAD, GSE15459, GSE29272, and GSE62254) and then validated with our samples at the protein level. LBH was overexpressed at both the mRNA and protein levels in cancer compared with normal tissues. High LBH expression was correlated with advanced T, N, and M stages. Kaplan-Meier analysis and log-rank test indicated that higher LBH expression was statistically correlated with shorter overall survival (OS) in the public datasets and our study samples. Univariate and multivariate Cox regression analysis showed that LBH was an independent prognostic biomarker for survival in TCGA-STAD, GSE15459, GSE62254 cohorts, and our GC patients.

Indexed as

Gastric cancerIntegrinLBHPrognositic biomarkerTCGA

Identifiers

PMID31119084
PMCPMC6507893
OpenAlexW2943104154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.